Dear Seed Investor,
As Recreational Cannabis Legalization Looms, the Field of Opportunity is Green for Canada’s Leading Growers
Medical cannabis use has been legal in Canada since 2001, and Canada is now working to become the first industrialized nation to input a comprehensive system permitting the recreational use of marijuana.
Sweeping legislation has been introduced by the Canadian government that takes aim at permitting nationwide recreational cannabis use by July 2018—a move applauded by companies that are currently licensed to produce medical marijuana in Canada or are engaged in providing services to growers—companies like ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) (ABcann Profile), which recently closed a milestone financing agreement with Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTC: KWFLF), an investor and supporter of cannabis cultivation companies, Canopy Growth Corp. (WEED: CN) (OTC: TWMJF), Aphria Inc. (TSX: APH) (OTC: APHQF), and Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF).
Despite the widespread legalization of medical marijuana in Canada, the licensing requirements for cannabis growers are incredibly strict, with only 3 percent of the growers who apply for licensing obtaining approval.
ABcann Global was one of Canada’s very first companies to successfully obtain licensure to produce medical cannabis.
ABcann compares impressively with other companies in Canada’s explosive medical cannabis industry—companies with much higher market caps and prices.
With Canada on the verge of blanket legalization of marijuana, the opportunity for investors is clear. In a country where stringent licensing standards have made cannabis growers few and far between, ABcann is a standout marijuana player to be reckoned with.
Read more here:
High Profits,
The Seed Investor
|
